Cassia Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-895
| Closed | -$360K | – | 61 |
|
|
2024
Q4 | $360K | Sell |
895
-742
| -45% | -$299K | 0.23% | 53 |
|
|
2024
Q3 | $761K | Sell |
1,637
-131
| -7% | -$60.9K | 0.5% | 35 |
|
|
2024
Q2 | $829K | Buy |
1,768
+92
| +5% | +$43.1K | 0.55% | 28 |
|
|
2024
Q1 | $701K | Buy |
1,676
+373
| +29% | +$156K | 0.47% | 40 |
|
|
2023
Q4 | $530K | Buy |
1,303
+71
| +6% | +$28.9K | 0.44% | 37 |
|
|
2023
Q3 | $428K | Buy |
1,232
+32
| +3% | +$11.1K | 0.35% | 42 |
|
|
2023
Q2 | $422K | Buy |
1,200
+240
| +25% | +$84.5K | 0.33% | 45 |
|
|
2023
Q1 | $302K | Sell |
960
-19
| -2% | -$5.99K | 0.24% | 46 |
|
|
2022
Q4 | $283K | Buy |
+979
| New | +$283K | 0.23% | 56 |
|